Functional Hemodynamic Monitoring: An Introduction
Key Questions and Principles Underlying Functional Hemodynamic Monitoring
Identifying Hypoperfusion and Non-invasive Assessment of Cardiovascular Reserve
PPV, SVV, and Volume Responsiveness
Intraoperative Fluid Management and Optimization Strategies
Limits of Preload-Responsiveness Approaches in Practice
Goal-directed therapy (GDT) has been taken as the gospel in critical care since the publication of Rivers et al.’s seminal paper on the topic demonstrating a mortality benefit in patients with severe sepsis and related shock back in late 2001, whose protocols were soon embraced and became ensconced in practice as standards of care, overlapping with other, high-acuity areas of medical specialty like surgery and emergency medicine. However, these initially results later became more mixed and equivocal on the whole when balanced in the context of more recent literature.
Fluid balance is paramount, and indiscriminate administration of fluids, either too conservatively or too liberally, is associated with mortality and significant morbidity in a diverse array of patient populations, and conventional, one-size-fits all approaches to fluid management do a disservice to both medical and surgical patients with dynamic needs.
In this learning activity, Dr. Michael R. Pinsky, MD, discusses the physiological principles underlying functional hemodynamic monitoring.
This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by Educational Grants from Cheetah Medical and Baxter Healthcare.
Release Date: December 09, 2019 -- Expiration Date: December 09, 2021
Faculty: Michael Pinsky, MD Dr hc
By the end of the session the participant will be able to:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through content review ScientiaCME.
Faculty Disclosure: Dr. Michael Pinsky, MD discloses that he is a consultant / speaker / grant recipient for Edwards Lifesciences, Masimo, LiDCO, Astra-Zeneca, Abbvie, Baxter, Cheetah Medical, Applied Physiology, Arrow International, Huntchinson Medical, and Vasamed.
Disclosures of Educational Planner: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.
Commercial Support Disclosure: This program is supported by an educational grant from Cheetah Medical and Baxter Healthcare.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.